CRY. CryoLife Reports 13% Revenue Growth for Third Quarter 2012 Increases Full Year 2012 Revenue and EPS Guidance Updated dial-in information for the 10 a.m. teleconference is contained in the press release below Third Quarter Highlights: - Total revenues grew 13% year-over-year to $33.4 million - Product revenues grew 13% year-over-year to $16.9 million - Tissue processing revenues grew 12% year-over-year to $16.4 million - EPS of $0.06, or $0.08 on a non-GAAP basis - Generated $6.1 million in cash flow from operations - Initiated $0.025 per share quarterly dividend http://finance.yahoo.com/news/cryolife-reports-13-revenue-growth-120400403.html
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.